The heart and cardiac pacing in Steinert disease

Acta Myologica

Volumn 31, Issue OCTOBER, 2012, Pages 110-116

  Nigro, Gerardo ^a   Papa, Andrea Antonio ^a   Politano, Luisa ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Arrhythmias; Cardiac pacing; Myotonic dystrophy type 1

Indexed keywords

CATARACT; DMPK GENE; GENE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; RESPIRATORY FAILURE; REVIEW; TRINUCLEOTIDE REPEAT; ALGORITHM; ATRIAL PREFERENCE PACING; ATRIOVENTRICULAR BLOCK; ATTENTION DISTURBANCE; CARDIAC RESYNCHRONIZATION THERAPY; CHOLELITHIASIS; COGNITIVE DEFECT; CONSTIPATION; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DYSPHAGIA; ELECTROCARDIOGRAPHY MONITORING; GASTROINTESTINAL OBSTRUCTION; GENE MUTATION; HEART ARRHYTHMIA; HEART ATRIUM APPENDAGE; HEART ATRIUM PACING; HEART DISEASE; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEREDITY; HYPOGONADISM; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; ISCHEMIC HEART DISEASE; MENTAL DEFICIENCY; MITRAL VALVE PROLAPSE; SUDDEN CARDIAC DEATH; SYSTOLIC DYSFUNCTION; THYROID DISEASE;

ATRIOVENTRICULAR BLOCK; CARDIAC PACING, ARTIFICIAL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HEART; HEART CONDUCTION SYSTEM; HUMANS; MYOTONIC DYSTROPHY; TACHYCARDIA;

MYOTONIC DYSTROPHY PROTEIN KINASE;

EID: 84869165711     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Emery AE. The muscular dystrophies. Lancet 2002;359:687-95. (Pubitemid 34203773)
2. Emery AE. Heritability of common neuromuscular diseases. Neuromuscul Disord 2010;20:476.
3. Harper PS. Myotonic Dystrophy: some genetic problems. Birth Defects Orig Artic Ser. 1974;10:120-5.
4. Harley HG, Brook JD, Rundle SA, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-6.
5. Walton JN. Clinical examination of the neuromuscular system. In: Sir John Walton, ed. Disorders of Voluntary Muscle. London: Churchill Livingstone 1981.
6. Nigro G, Comi LI, Politano L, et al. Cardiomyopathies associated with Muscular Dystrophies. In: Engel A, Franzini-Armstrong C. Myology. New York: Mac Graw-Hill 2004; pp. 1239-56 and references therein.
7. Hawley RJ, Gottdiener JS, Gay JA, et al. Families with myotonic dystrophy with and without cardiac involvement. Arch Intern Med 1983;143:2134-6. (Pubitemid 14225184)
8. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997;33:13-22. (Pubitemid 27019094)
9. Mathieu J, Allard P, Potvin L, et al. A 10 year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-62. (Pubitemid 29220644)
10. Pelargonio G, Dello Russo A, Sanna T, et al. Myotonic dystrophy and the heart. Heart 2002;88:665-70. (Pubitemid 35418097)
11. Melacini P, Villanova C, Menegazzo E, et al. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995;25:239-45.
12. Jaspert A, Fahsold R, Grehl, et al. Myotonic dystrophy correlation of clinical symptoms with the size of CTG repeats. J Neurol 1995;25:239-45.
13. Groh W, Lowe M, Zipes D. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol 2002;13:444-8. (Pubitemid 34494263)
14. Antonini G, Giubilei F, Mammarella A, et al. Natural history of cardiac involvement in myotonic dystrophy: correlation with CTG repeats. Neurology 2000;55:1207-9.
15. Clarke NRA, Kelion AD, Nixon J, et al. Does cytosine-thymine- guanine(CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart 2001;86:411-6. (Pubitemid 32889378)
16. Lazarus A, Varin J, Ounnoughene Z, et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 1999;99:1041-6. (Pubitemid 29104494)
17. Mankodi A, Thorton C. Myotonic syndrome. Curr Opin Neurol 2002;15:545-52.
18. D'Andrea A, Salerno G, Scarafile R, et al. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. Pacing Clin Electrophysiol 2009;32:1017-29.
19. Magri D, Piccirillo G, Bucci E, at al. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy Type 1: Beyond the cardiac conduction system. Int J Cardiol 2012;156:259-64
20. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995;25:746-52
21. Sovari AA, Bodine KC, Farokhi F. Cardiovascular manifestations of myotonic dystrophy-1. Cardiol Rev 2007;15:191-4. (Pubitemid 46956454)
22. Russo V, Rago A, Pannone B, et al. Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death. Eur J Haematol 2011;86:324-31.
23. Nigro G, Russo V, Rago A, et al. Heterogeneity of ventricular repolarization in newborns with severe aortic coarctation. Pediatr Cardiol 2012;33:302-6.
24. Buja G, Miorelli M, Turrini P, et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993;72:973-6. (Pubitemid 23298081)
25. Barr CS, Nass A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-9. (Pubitemid 24043180)
26. Paventi S, Bevilacqua U, Parafati MA, et al. QT dispersion and early arrhythmic risk during acute myocardial infarction. Angiology 1999;50:209-15. (Pubitemid 29138427)
27. Groh WJ, Groh MR, Chandan S, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy tipe 1. N Engl J Med 2008;358:2688-97. (Pubitemid 351860861)
28. Ducceschi V, Nigro G, Sarubbi B, et al. Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy. Int J Cardiol 1997;59:275-9. (Pubitemid 27240462)
29. Nigro G, Nigro G, Politano L, et al. Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients Heart 2002;87:156-7. (Pubitemid 34098379)
30. Ammendola E, Russo V, Politano L, et al. Is heart rate variability a valid parameter to predict sudden death in patients with Becker's muscular dystrophy? Heart 2006;92:1686-7. (Pubitemid 44629187)
31. Politano L, Palladino A, Nigro G, et al. Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies. Acta Myol 2008;27:114-22.
32. Politano L, Nigro G. Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results. Acta Myol 2012;31:24-30.
33. Lattanzi G, Benedetti S, Bertini E, et al. Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol 2011;30:138-43.
34. Russo V, Rago A, Palladino A, et al. P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. J Investig Med 2011;59:1151-4.
35. Benedetti S, Bernasconi P, Bertini E, et al. The empowerment of translational research: Lessons from laminopathies. Orphanet J Rare Dis 2012;7:37.
36. Nigro G, Russo V, Ventriglia VM, et al. Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery- Dreifuss muscular dystrophy. Neuromuscul Disord 2010;20:174-7.
37. Carboni N, Mura M, Mercuri E, et al. Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 2012;22:152-8.
38. Lancioni A, Rotundo IL, Kobayashi YM, et al. Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. Hum Mol Genet 2011;20:4644-54.
39. Rotundo IL, Faraso S, De Leonibus E, et al. Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy. PLoS One 2011;6:e24729.
40. Dello Russo A, Mangiola F, Della Bella P, et al. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study. J Cardiovasc Med (Hagerstown) 2009;10:51-8.
41. English KM, Gibbs JL. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. Dev Med Child Neurol 2006;48:231-5. (Pubitemid 44404273)
42. Morner S, Lindqvist P, Mellberg C, et al. Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1. J Int Med 2012;268:59-65.
43. Laurent V, Pellieux S, Corcia P, et al. Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. Int J Cardiol 2011;150:54-8.
44. Oloffson B, Forsberg H, Andersson S, et al. Electrocardiographic findings in myotonic dystrophy. Br Heart J 1988;59:47-52. (Pubitemid 18021566)
45. Chaudhry SP, Frishman WH. Myotonic dystrophies and the heart. Cardiol Rev 2012;20:1-3.
46. Bassez G, Lazarus A, Desguerre I, et al. Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1. Neurology 2004;63:1939-41. (Pubitemid 39532396)
47. Grigg LE, Chan W, Mond HG, et al. Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologicfeatures. J Am Coll Cardiol 1985;6:254-6. (Pubitemid 15069274)
48. Bhakta D, Lowe MR, Groh WJ. Prevalence of structural abnormalities in patients with myotonic dystrophy tipe 1. Am Heart J 2004;147:224-7. (Pubitemid 38176820)
49. Curtis AB, Dalal K. The role of implantable cardiac electrical devices in patients with myotonic dystrophy. J Cardiovasc Electrophysiol 2011;22:1376-7.
50. Russo V, Rago A, D'Andrea A, et al. Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. Anadolu Kardiyol Derg 2012;12:517-9.
51. Babuty D, Fauchier L, Tena-Carbi D, et al. Significance of late potentials in myotonic dystrophy. Am J Cardiol 1999;84:1099-101. (Pubitemid 29505387)
52. Cudia P, Bernasconi P, Chiodelli R, et al. Risk of arrhythmia in type I myotonic dystrophy: The role of clinical and genetic variables. J Neurol Neurosurg Psych 2009;80:790-3.
53. Lazarus A, Varin J, Babuty D, et al. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: A multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002;40:1645-52. (Pubitemid 35253643)
54. Bhakta B, Shen C, Kron J, et al. Pacemaker and implantable cardioverter defibrillator use in a U.S. Myotonic Dystrophy Type 1 population. J Cardiovasc Electrophysiol 2011; 22:1369-75.
55. Nigro G, Russo V, Vergara P, et al. Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation. Pacing Clin Electrophysiol 2008;31:1463-6.
56. Nigro G, Russo V, Politano L, et al. Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. Pacing Clin Electrophysiol 2009;32:1191-6.
57. Nigro G, Russo V, Politano L, et al. Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study. Europace 2010;12:1219-23.
58. Carlson M, Ip J, Messenger J, et al. A new pacemaker algorithm for the treatment of atrial fibrillation. Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-33. (Pubitemid 37000176)
59. Ogawa H, Ishikawa T, Matsushita K, et al. Effects of right Atrial Pacing Preference in prevention of paroxysmal atrial fibrillation. Atrial Pacing Preference Study (APP Study). Circ J 2008;72:700-4. (Pubitemid 351716672)
60. Gold M, Adler S, Fauchier L, et al. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 2009;6:295-301.
61. Nigro G, Russo V, Rago A, et al. The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. Pacing Clin Electrophysiol 2012;35:739-48.
62. Russo V, Rago A, Politano L, et al. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in Myotonic Dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. Europace 2012;14:486-9.
63. Task Force on Practice Guidelines: ACC/AHA/HRS 2008 guidelines for device based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force. Circulation 2008; 27;117:e350-408.